Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$7.08 -0.22 (-3.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Phathom Pharmaceuticals (PHAT) Liabilities and Shareholders Equity (2018 - 2026)

Updated

Phathom Pharmaceuticals' Liabilities and Shareholders Equity was $327.08 million in Q2 2026, up 30.7% from $250.22 million a year earlier and up 7.2% from the prior quarter.

Analysis

Phathom Pharmaceuticals (PHAT) Liabilities and Shareholders Equity (2018 - 2026) Analysis & Trends

At the end of FY2025, Liabilities and Shareholders Equity at Phathom Pharmaceuticals came in at $259.15 million, down 31.5% from FY2024.

  • Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -2.6% (FY2020 to FY2025).
  • In earlier years, Liabilities and Shareholders Equity was $378.32 million in FY2024 (-8.6%), $413.84 million in FY2023 (+151.1%), $164.81 million in FY2022 (-13.0%) and $189.43 million in FY2021 (-35.8%).
  • The Q2 2026 figure marks the highest quarterly Liabilities and Shareholders Equity since Q4 2024.
  • Compared with a year earlier, Liabilities and Shareholders Equity was higher in three of the last eight quarters, with an average decline of 2.4%.
  • The best year-over-year quarter for Liabilities and Shareholders Equity over five years was Q4 2023 (growth of 151.1%); the worst was Q1 2022 (a decline of 39.5%).
  • Per Business Quant data, PHAT's Liabilities and Shareholders Equity in the three quarters before Q2 2026 was $305.12 million (Q1 2026), $259.15 million (Q4 2025) and $240.29 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Phathom Pharmaceuticals 584.51 Mn -55.45 Mn 59.18 Mn 327.08 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 327.08 Mn
Mar 31, 2026 305.12 Mn
Dec 31, 2025 259.15 Mn
Sep 30, 2025 240.29 Mn
Jun 30, 2025 250.22 Mn
Mar 31, 2025 294.21 Mn
Dec 31, 2024 378.32 Mn
Sep 30, 2024 387.04 Mn
Jun 30, 2024 319.38 Mn
Mar 31, 2024 356.50 Mn
Dec 31, 2023 413.84 Mn
Sep 30, 2023 236.99 Mn
Jun 30, 2023 265.04 Mn
Mar 31, 2023 144.01 Mn
Dec 31, 2022 164.81 Mn
Sep 30, 2022 201.93 Mn
Jun 30, 2022 213.50 Mn
Mar 31, 2022 149.05 Mn
Dec 31, 2021 189.43 Mn
Sep 30, 2021 228.38 Mn
API Access

Phathom Pharmaceuticals Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PHAT&period=max&api_key=YOUR_API_KEY